Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Tricyclic 5alpha-reductase inhibitors designed at Merck & Co.

March 14, 2000

Phase III trial of Anogesic as treatment for anal fissure pain commences

March 13, 2000

In vitro and in vivo studies with specific chymase inhibitor suggest potential in atopic dermatitis

March 6, 2000

Wound-healing gene therapy using NAB2

Feb. 29, 2000

Pfizer presents new urokinase inhibitors for wound healing, etc.

Feb. 28, 2000

Pig small intestine submucosa shows efficacy in wound healing

Feb. 25, 2000

Modified oligonucleotides with staggered PS/PO linkages designed at Isis

Feb. 24, 2000

Switch Biotech files patent applications for wound-healing genes

Feb. 23, 2000

Topical tazarotene effective in congenital ichthyosis

Feb. 18, 2000

Antipsoriatic activity of EGF receptor tyrosine kinase inhibitor SU-5271

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...